Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX04 Versus Avastin® in Healthy Male Subjects
Clinical trial NCT03483649 · COMPLETED
Trial details
- NCT number
- NCT03483649
- Sponsor
- Shanghai Henlius Biotech
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-21
- Primary completion
- 2017-10-29
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.